|
Real-time Estimate
Cboe BZX
15:04:45 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 262.24 USD | -0.12% |
|
-4.94% | +100.51% |
| 09:43am | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 05:49am | Analyst recommendations: ConocoPhillips, Datadog, Intel, Fair Isaac, MGM Resorts… |
Company Valuation: Illumina, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 59,407 | 30,014 | 22,570 | 21,454 | 20,620 | 39,644 | - | - |
| Change | - | -49.48% | -24.8% | -4.95% | -3.88% | 92.25% | - | - |
| Enterprise Value (EV) 1 | 59,763 | 30,712 | 23,005 | 22,223 | 20,976 | 39,605 | 38,595 | 37,418 |
| Change | - | -48.61% | -25.09% | -3.4% | -5.61% | 88.81% | -2.55% | -3.05% |
| P/E | 75.4x | -6.81x | -19.4x | -17.6x | 24.8x | 53.1x | 44.2x | 37.7x |
| PBR | 5.56x | - | 3.93x | 9.06x | 7.63x | 13.1x | 11x | 9x |
| PEG | - | 0x | 0.3x | -3.69x | -0x | -5.75x | 2.2x | 2.2x |
| Capitalization / Revenue | 13.1x | 6.55x | 5.01x | 4.91x | 4.75x | 8.57x | 8.05x | 7.51x |
| EV / Revenue | 13.2x | 6.7x | 5.11x | 5.08x | 4.83x | 8.56x | 7.84x | 7.09x |
| EV / EBITDA | 46.8x | 43.4x | 47.1x | 27.5x | 17.4x | 30.5x | 26.5x | 23.5x |
| EV / EBIT | 54.5x | 63.1x | 93.1x | 38.3x | 20.9x | 36.4x | 31.4x | 26.8x |
| EV / FCF | 177x | 290x | 81.3x | 32x | 22.5x | 44.3x | 31.4x | 27.6x |
| FCF Yield | 0.56% | 0.35% | 1.23% | 3.13% | 4.44% | 2.26% | 3.18% | 3.63% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 5.04 | -28 | -7.34 | -7.69 | 5.45 | 4.947 | 5.94 | 6.965 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 4,526 | 4,584 | 4,504 | 4,372 | 4,343 | 4,624 | 4,923 | 5,276 |
| EBITDA 1 | 1,277 | 708 | 488 | 807 | 1,208 | 1,300 | 1,459 | 1,590 |
| EBIT 1 | 1,096 | 487 | 247 | 580 | 1,004 | 1,087 | 1,228 | 1,395 |
| Net income 1 | 762 | -4,404 | -1,161 | -1,223 | 850 | 772.8 | 912.1 | 1,067 |
| Net Debt 1 | 356 | 698 | 435 | 769 | 356 | -38.82 | -1,048 | -2,226 |
| Reference price 2 | 380.07 | 190.81 | 142.13 | 135.27 | 134.95 | 262.54 | 262.54 | 262.54 |
| Nbr of stocks (in thousands) | 156,305 | 157,300 | 158,800 | 158,600 | 152,800 | 151,000 | - | - |
| Announcement Date | 2/10/22 | 2/7/23 | 2/8/24 | 2/6/25 | 2/5/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 53.07x | 8.56x | 30.46x | -.--% | 39.64B | ||
| 34.27x | 5.99x | 22.93x | 0.27% | 255B | ||
| 38.97x | 6.89x | 21.81x | 0.63% | 161B | ||
| 45.34x | 12.27x | 27.06x | -.--% | 151B | ||
| 16.68x | 3.34x | 10.9x | -.--% | 64.33B | ||
| 20.33x | 2.44x | 12.33x | 2.49% | 51.9B | ||
| 47.52x | 11.7x | 25.8x | -.--% | 50.25B | ||
| 34.83x | 6.84x | 21.72x | -.--% | 49.92B | ||
| 33.7x | 6.66x | 22.63x | 0.59% | 48.77B | ||
| 76.49x | 7.3x | 22.21x | -.--% | 42.93B | ||
| Average | 40.12x | 7.20x | 21.78x | 0.4% | 91.46B | |
| Weighted average by Cap. | 38.42x | 7.36x | 22.33x | 0.36% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ILMN Stock
- Valuation Illumina, Inc.
Select your edition
All financial news and data tailored to specific country editions
















